Detalhe da pesquisa
1.
Seroprevalence of IgM and IgG Against SARS-CoV-2 after Two Doses of Pfizer-BioNTech COVID-19 Vaccine in Women with Breast Cancer.
Clin Lab;
68(11)2022 Nov 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36378000